Dr. Lemon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
14780 W. Mountain View Blvd
Ste. 120
Surprise, AZ 85374Phone+1 623-215-9760
Summary
- Dr. Stephen Lemon is a medical oncologist serving the Phoenix, AZ area. He specializes in breast cancer, cancer genetics/cancer risk assessment, and medical oncology. After earning his B.S from Gonzaga University, he pursued an MPH at Johns Hopkins School of Public Health and completed his MD at the University of Washington School of Medicine. His further education included an internal medicine residency at Sparrow Hospital/Michigan State University and a fellowship in hematology and medical oncology at National Institutes of Health Clinical Center. He has served in various capacities including as an Assistant Professor at Creighton University School of Medicine. He has worked with the Fred Hutch Cancer Center in Bellevue, WA and is currently a medical oncologist for the Oncology Care Partners in the Phoenix, AZ area. He's published several research articles and has been involved in numerous clinical trials. Over the years, he has been recognized for his contributions to medicine with awards such as the Delta Omega Honor Society in Public Health and the Alpha Omega Alpha Honor Medical Society.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1993 - 1995
- John Hopkins School of Hygiene and Public HealthMPH, 1991 - 1992
- Johns Hopkins School of Hygiene and Public HealthMPH, 1991 - 1992
- Johns Hopkins School of Hygiene and Public HealthMPH, 1991 - 1992
- Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 1988 - 1991
- University of Washington School of MedicineClass of 1988
- Gonzaga UniversityB.S., 1979 - 1983
- Gonzaga UniversityB.S., 1979 - 1983
Certifications & Licensure
- AZ State Medical License 2024 - 2025
- WA State Medical License 2005 - 2025
- NE State Medical License 1995 - 2021
- IA State Medical License 2003 - 2018
- MD State Medical License 1992 - 1996
- MI State Medical License 1988 - 1995
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Delta Omega Honor Society in Public Health, Alpha Chapter 1992
- Alpha Omega Alpha Honor Medical Society Michigan State University College of Human Medicine, 1991
- B. H. Smookler Endowment Award Michigan State University Associated Hospitals, Internal Medicine Residency, 1991
- Join now to see all
Clinical Trials
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
- Vitamin D and Breast Cancer Biomarkers in Female Patients Start of enrollment: 2010 Oct 01
- CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- 40 citationsEtiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications.Henry T. Lynch, Stephen J. Lemon, Beth Karr, Barbara Franklin, Jane F. Lynch
Cancer Epidemiology, Biomarkers & Prevention. 1997-12-01 - 173 citationsColorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family membersPatrice Watson, Kevin M. Lin, Miguel A. Rodriguez-Bigas, Thomas C. Smyrk, Stephen J. Lemon
Cancer. 1998-07-15 - 172 citationsFamilial pancreatic cancer: a review.Henry T. Lynch, Thomas C. Smyrk, Scott E. Kern, Ralph H. Hruban, C. J. Lightdale
Seminars in Oncology. 1996-04-01
Lectures
- Breast Cancer Genetics9/24/2009
- Trends in Cancer Care and Treatment Options4/16/2009
- What You Should Know About Breast Cancer10/1/2008
- Join now to see all
Press Mentions
- Phase II Lung Cancer Clinical Trial Could Bring Another Immunotherapy Option to Mesothelioma PatientsMay 26th, 2016
Professional Memberships
- Member
Other Languages
- Spanish
External Links
- SCCA @ Overlakehttps://www.seattlecca.org/about/locations/overlake-medical-center
- Lighter Side of Cancerhttps://lightersideofcancer.com/
- Facebookhttps://www.facebook.com/LighterSideOfCancer/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: